ARCHIVES

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

This article is from The Cancer Letter archive.

Vol. 23 No. 01 | January 10, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: Pretreatment Critical In Antimetic Therapy, Sallan Says; Aging/Cancer Symposium Planned

July 11, 1980

Research Advocates Prepare to Face Republican-led Congress

December 19, 2014

USC Cancer Center Plans Expansion, Gets New Name

January 27, 1989

Increase In Recommended Levels, OMB’s Forward Funding Create Shortfall In Center’s Budget

April 19, 1985

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

Recombinant TSH Avoids Need To Stop Replacement Therapy

January 27, 2006